In a recent study published in Cell, Xu et al. have uncovered a critical role for the endoplasmic reticulum (ER) stress sensor inositol-requiring enzyme 1 alpha (IRE1α) in modulating the immunogenic effects of taxane chemotherapy in triple-negative breast cancer (TNBC). The gene discussed is ERN1; the disease is triple-negative breast carcinoma.